News

US FDA to convene expert panel for Capricor Therapeutics' DMD cell therapy
Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts ...
STAT16h
FDA will ask outside experts to review Capricor’s therapy for Duchenne muscular dystrophy
From STAT’s Adam Feuerstein: The FDA informed Capricor Therapeutics that a meeting of outside experts will be convened to ...